This week, one Waltham biotech announced a deal to work with AbbVie that will pay out $52M upfront, while another one made workforce cuts. Meanwhile, two Massachusetts biotechs lost their financial ...

Sales growth of 7%, GAAP EPS of $3.19 and Adjusted EPS of $4.26On track to close De La Rue Authentication acquisition in the ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Crane NXT, Co. (CXT) on Wednesday reported fourth-quarter profit of $57.6 million. The Waltham, Massachusetts-based company said it had net income of $1 per ...

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Xilio Therapeutics shares took flight in premarket trading Wednesday after the clinical-stage biotechnology company formed a potentially lucrative collaboration with AbbVie that includes an equity ...

AbbVie and Xilio Therapeutics have inked a collaboration and option-to-license agreement potentially worth more than $2 billion to clinical-stage biotechnology company Xilio.

A Falmouth senior netted back-to-back hat tricks, and players from Beverly/Danvers, Burlington, Milton, ...

Davis Cos. has unveiled its latest plan for the Waltham property after it scrapped a lab proposal and got hit with a lawsuit from the site’s former owner.